Top News

Ignyta Raises $1M In Venture Debt

San Diego-based personalized medicine developer Ignyta has raised $1M in funding, via a capital term loan from Silicon Valley Bank, the company disclosed this morning. The firm--which is focusing on treating rheumatoid arthritis (RA), lupus and other autoimmune diseases, said the new $1M capital term loan facility comes on top of an existing, $500K facility it has with SVB. Financial details of that term loan were not disclosed. Ignyta is venture backed by Colt Ventures, City Hill Ventures, and others.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel